4
Changes in Ownership
FATE THERAPEUTICS INC Filed Acc 0001209191-23-003338
Director bought 124,679 shares at an average $5.60 ($698,138)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MENDLEIN JOHN Director | 2023-01-11 | Purchase | +88,048 | $5.67 | $499,232 | 246,139 | D |
| MENDLEIN JOHN Director | 2023-01-13 | Purchase | +36,631 | $5.43 | $198,906 | 282,770 | D |
| Open-market purchases · 124,679 sh · avg $5.60 · $698,138 | |||||||
Loading xslF345X03/doc4.xml…